Users Stopping Weight-Loss Medications Gain Back Weight Four Times Faster Than Those on Conventional Diets

A recent study indicates that individuals who discontinue popular slimming jabs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle regimens.

Research printed in a major health publication shows that while obese individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight returns at an average rate of nearly a kilo each month after stopping.

"Users using these treatments need to be cognizant of the potential of rapid rebound weight gain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to pre-treatment weight within about a year and a half.

Analyzing Therapies

The analysis, which examined dozens of studies involving thousands of patients, compared the effects of the injectable medications with other pills.

Researchers point out that people who lose weight through dieting usually have a more gradual creep back—around 0.1 kg a month—post-intervention.

The Reason for the Quick Rebound

Doctors believe the mechanism of the injections accounts for the amplified rebound.

These medications copy a natural hormone called GLP-1, which moderates feelings of fullness.

"Artificially providing the hormone concentrations several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication means hunger is no longer kept in check, making excessive eating a significant risk."

An Ongoing Disease?

Health authorities suggest the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.

A number of clinicians argue that, due to the high risk of weight regain, the therapy should be considered ongoing.

This opinion is reinforced by pharmaceutical companies, who say that the results "emphasize the persistent nature of excess weight," akin to managing diseases like hypertension.

Patient Experiences

Individuals who have stopped the jabs explain a intense return of appetite.

"It felt as if a trigger activating and you're instantly starving," said an individual.

This difficulty is compounded if individuals have not developed sustainable lifestyle or habit changes during treatment.

Growing Use

Survey data indicate that a significant number of people in the UK have tried these injections in the past year, with desire remaining high.

• Adoption is more common among women than males.
• The 40s and 50s age group shows the highest level of interest.
• A large proportion access the drugs through private prescriptions rather than the NHS.

In conclusion, researchers stress that while these medications are powerful tools for weight loss, they are not a standalone cure and maintained weight loss relies on combined lifestyle management.